The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunoparesis in newly diagnosed AL amyloidosis as a marker for response and survival.
 
Eli Muchtar
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - GlaxoSmithKline (Inst); Prothena (Inst)
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Shaji Kumar
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Martha Lacy
Research Funding - Celgene (Inst)
 
Steven R. Zeldenrust
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
Nelson Leung
No Relationships to Disclose
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Wilson I. Gonsalves
No Relationships to Disclose
 
Rajshekhar Chakraborty
No Relationships to Disclose
 
Stephen J. Russell
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
John Anthony Lust
No Relationships to Disclose
 
Yi Lin
No Relationships to Disclose
 
Prashant Kapoor
No Relationships to Disclose
 
Ronald S. Go
No Relationships to Disclose
 
Robert A. Kyle
Consulting or Advisory Role - Aeterna Zentaris; Bristol-Myers Squibb; Celgene; Novartis; Onyx; Pharmacyclics
 
S.Vincent Rajkumar
No Relationships to Disclose
 
Morie A. Gertz
Honoraria - Celgene; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sanofi
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena